RIYADH, Saudi Arabia, Aug. 22, 2024 (Korea Bizwire) – By continuously adopting new technologies, KFSHRC ensures that its trainees are well-prepared for today’s medical challenges and equipped with the skills and knowledge needed to lead the future of medicine. These technologies bridge the gap between theory and practice and prepare healthcare professionals to lead in [...]
VANCOUVER, British Columbia, Aug. 22, 2024 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced that management will participate in the following upcoming investor conferences: Wells Fargo Healthcare Conference: Zymeworks’ management will participate in [...]
Advancing Pharmaceutical Innovation: Brains Bioceutical’s CEP Certification will Streamline Cannabinoid Drug Development, Inspired by Jazz Pharmaceuticals’ CBD-Based Epilepsy Drug and 2024 $1.4 Billion Revenue Projection SANDWICH, United Kingdom, Aug. 22, 2024 (Korea Bizwire) – Brains Bioceutical Corp. (BBC) has achieved a groundbreaking milestone by submitting one of the world’s first CEP (Certification of Suitability) application [...]
RIYADH, Saudi Arabia, Aug. 20, 2024 (Korea Bizwire) – King Faisal Specialist Hospital & Research Centre (KFSHRC) is further expanding its global footprint by participating in the 2024 International Association for Medical Education in Europe (AMEE) Conference for the second consecutive year. Taking place from August 26 to 28 in Basel, Switzerland, this event brings [...]
August 20, 2024 Integrated Philips cardiovascular solutions enhance the patient & staff experience with reduced X-ray dose & procedure time for more time with patients and to help improve outcomes New facility will have 11 specialized Philips interventional suites, allowing physicians to treat patients with complex cardiovascular conditions closer to home Amsterdam, The Netherlands and [...]
WASHINGTON, Aug. 20, 2024 (Korea Bizwire) – Virologist and vaccine development leader Kelly Warfield has joined the Sabin Vaccine Institute as its Research & Development President to drive Sabin’s current candidate vaccines toward licensure and expand its pipeline. A member of Sabin’s executive team, Warfield will manage the R&D program and team, collaborating with peers, [...]
The GVN MPOX Action Committee is poised to mobilize resources and catalyze efforts in the urgent global call to action TAMPA, Fla., Aug. 16, 2024 (Korea Bizwire) – As the World Health Organization (WHO) declares MPOX a public health emergency of international concern, the Global Virus Network (GVN), headquartered at the University of South Florida (USF), [...]
Protocol SmartDesign and Investigator SmartSelect bring treatments to patients faster by accelerating clinical trial development NEW YORK, Aug. 13, 2024 (Korea Bizwire) – Citeline, a leader in intelligence solutions for the life sciences industry, has launched two new products — Protocol SmartDesign and Investigator SmartSelect — in its Citeline SmartSolutions suite accelerating the path from pipeline [...]
August 13, 2024 Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Isala hospital (Zwolle, The Netherlands) have renewed their long-term strategic partnership to enhance healthcare delivery through innovative and cost-effective solutions. This collaboration aims to ensure healthcare remains accessible, available, and affordable by leveraging Philips’ advanced technology, data analytics, [...]
SHANGHAI, Aug. 12, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the National Medical Products Administration (NMPA) has accepted for review the supplemental new drug application (sNDA) for toripalimab (trade name: [...]